JCO oncology practice

· 1 paper in corpus
review 2022
doi:10.1200/op.21.00382 ·PMID:34582274

Pathogenic germline variants underlie up to 20% of ovarian cancer (OC) and are associated with varying degrees of risk for OC. For mutations in high-penetrance genes such as BRCA1/2, the role of risk-reducing bilateral salpingo-oophorectomy…